3-cyanoquinoline inhibitors of tpl2 kinase and methods of...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 215/42 (2006.01) A61K 31/4706 (2006.01) A61P 29/00 (2006.01) C07D 215/44 (2006.01)

Patent

CA 2608540

The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, m and n are defined as described herein. The invention also provides methods of making the compounds of formula (I), and methods of treating inflammatory diseases, such as rheumatoid arthritis, in a mammal comprising administering a therapeutically effective amount of a compound of formula (I) to the mammal.

L'invention concerne des composés de formule (I): (I), et des sels pharmaceutiquement acceptables de ces composés, R1, R2, R3, R4, R5, R6, R7, R8, m et n étant comme définis dans la description. La présente invention porte également sur des procédés pour produire des composés de formule (I), et sur des méthodes pour traiter des maladies inflammatoires telles que la polyarthrite rhumatoïde chez un mammifère, par administration d'une quantité thérapeutiquement suffisante d'un composé de formule (I) au mammifère.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

3-cyanoquinoline inhibitors of tpl2 kinase and methods of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3-cyanoquinoline inhibitors of tpl2 kinase and methods of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-cyanoquinoline inhibitors of tpl2 kinase and methods of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1385171

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.